145,211 members

Skip to content. | Skip to navigation

News

Landmark NHS deal to open up access to life-changing cystic fibrosis drug

 

Start sharing

If you've got news you'd like to share, let us know and we'll consider it for our news section.
 

Landmark NHS deal to open up access to life-changing cystic fibrosis drug

NHS patients will be among the first in Europe to be prescribed Kaftrio, which significantly improves lung function, helping people with cystic fibrosis to breathe more easily and enhancing their overall quality of life.

The treatment – known as the ‘triple combination therapy’ – was given the green light by European regulators this week, setting live a deal struck by NHS England to get the drug onto the frontline of patient care as soon as it was licensed.